Tag: manufacturing
-
US Govt to Buy 1.25M Regeneron Covid-19 Therapies
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion.
-
Infographic – Countries Making Covid-19 Vaccines
The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges.
-
CureVac, Bayer Partner on Covid-19 Vaccine Supply
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine.
-
Trial OKed for Rare Disease Gene Therapy
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease.
-
Essay – Enlist U.S. Retailers for Vaccine Distribution
A promising solution for vaccine distribution is staring policy-makers in the face, on street corners and shopping centers across the U.S., retail chain stores.
-
Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant
A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin.
-
Challenge Seeks Sustainable Chicken, Fish Alternatives
A new challenge competition from XPrize is looking for alternatives to chicken and fish that look and taste like the real thing, but are friendlier to the planet.
-
Biotech Manufacturing, Distribution Company Underway
A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations.
-
Stem Cell Respiratory Therapy Licensed in $1.4B Deal
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections.
-
Start-Up Gains Drug Nanoparticle Manufacturing Tech
A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles.